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Adrenocortical and Pituitary Glucocorticoid Feedback in
Abstinent Alcohol-Dependent Women
Bryon Adinoff, Susan E. Best, Wen Ye, Mark J. Williams, and Ali Iranmenesh
Background: The long-term ingestion of alcohol diminishes hypothalamic–pituitary–adrenal
(HPA) axis reactivity in alcohol-dependent men, potentially altering future relapse risk. Although
sex differences in HPA axis functioning are apparent in healthy controls, disruptions in this sys-
tem have received little attention in alcohol-dependent women. In this study, we assessed the basal
secretory profile of adrenocorticotropic hormone (ACTH) and cortisol, adrenocortical sensitivity
in both the presence and absence of endogenous corticotropic pituitary activation, and feedback
pituitary glucocorticoid sensitivity to dexamethasone.
Methods: Seven women 4- to 8-week abstinent alcohol-only dependent subjects and 10 age-
matched female healthy controls were studied. All subjects were between 30 and 50 years old, not
taking oral contraceptives, and were studied during the early follicular phase of their menstrual
cycle. Circulating concentrations of ACTH and cortisol were measured in blood samples collected
at frequent intervals from 2000 to 0800 hour. A submaximal dose of cosyntropin (0.01 lg ⁄ kg),
a synthetic ACTH (1–24), was administered at 0800 hour to assess adrenocortical sensitivity. In a
separate session, low-dose cosyntropin was also administered following high-dose dexamethasone
(8 mg intravenous) to assess adrenocortical sensitivity in the relative absence of endogenous
ACTH. In addition, the ACTH response to dexamethasone was measured to determine the pitui-
tary glucocorticoid negative feedback. Sessions were 5 days apart, and blood draws were obtained
every 5 to 10 minutes.
Results: Mean concentrations and pulsatile characteristics of ACTH and cortisol over 12 hours
were not statistically different between the 2 groups. Healthy controls had a somewhat higher
(p < 0.08) net peak, but not net integrated, cortisol response to cosyntropin relative to the
alcohol-dependent women. There were no significant group differences in either the ACTH or
cortisol response to dexamethasone nor in the net cortisol response to cosyntropin following
dexamethasone.
Conclusion: Significant differences in pituitary–adrenal function were not apparent between
alcohol-dependent women and matched controls. Despite the small n, it appears that alcohol-
dependent women do not show the same disruptions in HPA activity as alcohol-dependent men.
These findings may have relevance for gender-specific treatment effectiveness.
Key Words: Adrenal Cortex, Alcoholism, Cosyntropin, Dexamethasone, Pituitary-Adrenal
System, Gender, Female.
A WEALTH OF literature supports disruptions of thehypothalamic–pituitary–adrenal (HPA) axis activity in
alcohol-dependent men. Whereas increases in cortisol are
observed during intoxication (Adinoff et al., 2003; Mendelson
et al., 1971; Stokes, 1973) and withdrawal (Adinoff et al.,
1991; Iranmanesh et al., 1989; Keedwell et al., 2001;
Mendelson et al., 1971), an attenuated adrenocorticoid
response to both the behavioral and pharmacological activa-
tion of the HPA axis (Adinoff et al., 1998) has been observed
during the early weeks of abstinence. Diminished glucocorti-
coid reactivity has been reported in alcohol-dependent sub-
jects following an alcohol challenge (Merry and Marks,
1972), insulin-induced hypoglycemia (Chalmers et al., 1978;
Costa et al., 1996), exercise (Coiro et al., 2007), operative
trauma (Margraf et al., 1967), nicotine (Coiro and Vescovi,
1999), corticotropin releasing hormone (CRH) stimulation
(Adinoff et al., 2005b; Bailly et al., 1989), cosyntropin stimu-
lation (Adinoff et al., 2005a; Wand and Dobs, 1991), hyper-
thermia (Vescovi et al., 1997), cold pressor (Errico et al.,
1993), mental arithmetic (Errico et al., 1993), and public
speaking (Lovallo et al., 2000). The clinical relevance of these
findings has been suggested by recent studies demonstrating
that attenuated basal glucocorticoid concentrations (Kiefer
et al., 2006) or a hyporeactive adrenocortical response
(Junghanns et al., 2003) predict prospective relapse.
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These findings, however, have been almost exclusively
assessed in alcohol-dependent men. The aforementioned ref-
erenced studies measuring pituitary–adrenal responsivity
(Chalmers et al., 1978; Coiro et al., 2007; Coiro and Vescovi,
1999; Costa et al., 1996; Ehrenreich et al., 1997; Errico et al.,
1993; Junghanns et al., 2003; Knudsen et al., 1987; Lovallo
et al., 2000; Merry and Marks, 1972; Vescovi et al., 1997;
Wand and Dobs, 1991), for example, consisted of 276
alcohol-dependent men and no alcohol-dependent women.
There are several likely reasons accounting for this representa-
tional bias. First, there are more male than female alcohol-
dependent subjects (Kandel et al., 1997), though this clearly
would not account for the absence of women in this literature.
Second, many studies are conducted in the Veterans Adminis-
tration hospitals, which treat primarily male subjects. Perhaps
more important, however, is the difficulty in correctly study-
ing neuroendocrine parameters in female alcohol-dependent
subjects. Women are more likely to suffer from co-morbid
psychiatric disorders than their male counterparts (Brady
et al., 1993; Najavits et al., 1997), requiring the exclusion of
many, if not most, female subjects. Most problematic is that
the neuroendocrine system in women should optimally be
assessed during a period of relative hormonal stability, requir-
ing a similar hormonal phase of life (i.e., premenopausal)
between subjects, a matched (and preferably quiescent) men-
strual phase, and absent the use of synthetic hormonal treat-
ment (i.e., oral contraceptives) (Kirschbaum et al., 1999) that
may alter HPA axis responsivity. To assess menstrual phase
without resorting to the frequent measurement of gonado-
tropic hormones also requires the presence of a functionally
intact uterus and regular menses. Given the irregular menses
frequently observed in alcohol-dependent women, particularly
during short-term abstinence, these collective difficulties can
be daunting.
Nevertheless, stress-hormone reactivity in alcohol-depen-
dent women requires investigation. Because of significant gen-
der differences in HPA axis reactivity to both behavioral and
pharmacological stimuli (Shalev et al., 2008; Uhart et al.,
2006), coupled with gender-specific genetic modulators
(Shalev et al., 2008), findings in men may not generalize to
women. Increased rates of stress-related psychiatric disorders
in alcohol-dependent women, such as Post-traumatic Stress
Disorder (Brady et al., 1993; Najavits et al., 1997) or Major
Depressive Disorder, suggest that biological processes under-
lying stress may also differ in female compared to male
alcohol-dependent subjects. Given the role of stress in relapse
and the aforementioned putative relationship between hypo-
adrenocortical reactivity and relapse risk, an understanding
of pituitary–adrenal responsiveness takes on increased impor-
tance in this vulnerable population. Finally, the finding of
adrenocortical hyporeactivity in alcohol-dependent subjects is
not universally observed (Adinoff et al., 1990; Anthenelli
et al., 2001; Brady et al., 2006; George et al., 1994; Inder
et al., 1995; Munro et al., 2005), indicating the need for
additional studies in both genders. In addition, few studies
have separately assessed the contribution of the adrenal
cortex relative to higher-level organs (hypothalamus or pitui-
tary gland) in alcohol-dependent patients.
In this study, we conducted a series of experiments to assess
the pituitary–adrenal function in abstinent alcohol-dependent
women and compared their results to age-matched healthy
controls. All subjects were without a lifetime history of Axis I
disorders (other than alcohol-dependence in the patient sam-
ple or nicotine dependence in either group), were not taking
oral contraceptives, and were studied immediately after the
onset of their menses. As previous research suggests that
the blunted pituitary–adrenal response in alcohol-dependent
subjects is because of an attenuated adrenocorticoid response—
even in the presence of sufficient ACTH stimulation
(Adinoff et al., 2005b)—we focused our investigation upon
the adrenal cortex. (Pituitary ACTH is secreted in response
the release of hypothalamic cCRH. The release of ACTH
into the bloodstream then induces the release of cortisol
from the adrenal cortex.) Several paradigms, therefore,
were performed to assess the integrity of the adrenal cortex.
First, basal pulsatile characteristics of ACTH and cortisol
were assessed from 2000 to 0800 hour. Because of safety
limitations on the amount of blood withdrawn, measures of
basal pulsatility were limited to the period of greatest
ACTH and cortisol activity (e.g., 2000 to 0800 hour). Sec-
ond, adrenocorticoid sensitivity was assessed in response to
cosyntropin, a synthetic ACTH (ACTH1-24). This paradigm
allowed us to directly determine responsivity of the adrenal
cortex without the confound of concurrent pituitary ACTH
stimulation. In order to avoid a maximal glucocorticoid
response, or ceiling effect, that could obscure potential
group differences, we assessed adrenocortical sensitivity
with a very low dose (0.01 lg ⁄kg) of cosyntropin [0.3% of
the clinically recommended dose (250 lg) used in the cosyn-
tropin stimulation test in the diagnosis of endocrine disor-
ders]. Even in this procedure, however, group differences
in endogenous basal concentrations of ACTH may alter
glucocorticoid responsivity. A third paradigm, therefore,
assessed adrenocorticoid responsivity in the near absence of
endogenous ACTH. Suppression of pituitary ACTH was
accomplished by administering high-dose dexamethasone
the night prior to cosyntropin administration. Dexametha-
sone administration also allowed the assessment of negative
glucocorticoid feedback upon the pituitary corticotrophs.
Given the paucity of previous studies in this area, we pre-
dicted that the alcohol-dependent women would respond
comparatively to the alcohol-dependent men. Thus, our origi-
nal hypothesis was that adrenocortical reactivity would be
blunted in alcohol-dependent women, relative to control
women, following cosyntropin both with and without dexa-
methasone pretreatment.
MATERIALS AND METHODS
Alcohol-Dependent Subjects (see Table 1)
Seven female alcohol-dependent subjects, ranging in age from 30
to 43 y ⁄o, were recruited from patients requesting treatment for
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alcohol dependence at Homeward Bound, Inc. or the Dallas VA
Medical Center. All 7 subjects participated in both study sessions.
Patients reported an alcohol intake of at least 80 gms of absolute
alcohol on a daily basis for at least 2 weeks prior to the cessation of
drinking, and had at least a 10-year history of problematic drinking.
Patients with other lifetime DSM-IV Axis I psychiatric disorders
(such as anxiety, post-traumatic stress, schizophrenia, or mood dis-
orders) not associated with alcohol use (i.e., present prior to heavy
drinking or following at least months abstinence), other Substance
Use Disorders (or use of another drug more than once weekly) within
the previous 12 months (excluding caffeine or nicotine use disorders),
medical disorders (i.e., hypertension, diabetes, chronic pain, or car-
diac or pulmonary disorders), or major head trauma were excluded
from the study. Exclusion criteria also included use of any medica-
tions that may interfere with HPA axis functioning (i.e., psychotrop-
ics, antihypertensives, hypoglycemic agents, oral hypoglycemics)
within 2 weeks of the study, Beck Depression Inventory (Beck et al.,
1979) (BDI) scores above 15 at the time of assessment, or an alanine
aminotransferase or aspartate aminotransferase 3.0 times greater
than the clinical laboratory’s upper limit of normal.
Healthy Controls
Eleven healthy control women, ranging in age from 30 to 44 years
old, were individually age-matched within a 5-year period with
alcohol-dependent subjects. Controls reported no lifetime history of
any DSM-IV Axis I Disorder (except Nicotine Use Disorders),
reported no medical disorders, and were on no medications. Controls
with a single first-degree relative or two second-degree relatives with
an Axis I disorder were excluded.
Clinical Assessment (See Table 1)
All subjects obtained a history and physical exam, routine clinical
laboratory testing, electrocardiogram, and urine drug screens. Psychi-
atric and substance use disorders were assessed using the Structured
Clinical Interview for DSM IV (SCID)-Lifetime (First et al., 1996).
Alcohol-dependent subjects were detoxified from alcohol, and then
housed on a residential treatment unit until the studies were initiated.
Urine drug screens were obtained 3 times weekly and breathalyzers
were obtained whenever the patient left the unit unaccompanied by
staff. Separate informed consents from both the University of Texas
Southwestern Medical Center and the Dallas VA Medical Center
Internal Review Boards (IRBs) were obtained after the study was
fully explained, and subjects were financially compensated for their
participation. In the patient population, the Drinker Inventory of
Consequences – Lifetime Consequences (DrInC-2L) (Miller et al.,
1995) was used to assess lifetime severity of alcohol-related problems,
and a Time-Line Follow Back (Sobell and Sobell, 1978) (TLFB) was
used to assess 1-month, 90-day, 1-year, and lifetime drinking history.
Procedure
All neuroendocrine studies were performed at the General Clinical
Research Center (GCRC) at the University of Texas Southwestern
Medical Center. The studies were performed in 2 separate sessions.
The initial session was initiated the day after the onset of menses. In
order to assess each subject during the early follicular phase of their
menstrual cycle, the sessions were separated by 5 days rather than
the 1-week interval used in prior studies of male subjects. Session
order was balanced. A nicotine patch was placed on all nicotine-
dependent subjects upon arrival to the GCRC and was continued
throughout their hospitalization. All smokers reported smoking more
than 10 cigarettes daily and were administered one 21 mg patch every
24 hours.
Session A. This study included a 24-hour urine collection for uri-
nary free cortisol, 12-hour sampling for the measurement of plasma
ACTH and cortisol secretory dynamics and 2-hour cosyntropin stim-
ulation test. Because of IRB limitations on the amount of blood
obtained (350 ml over 6 weeks), it was necessary to limit our assess-
ment of circadian pulsatility to a 12-hour period. The interval from
2000 to 0800 hour was chosen because of the increased pulsatility
observed during this period. Subjects were brought to the GCRC
at 1800 hour on Day 1. A 24-hour urine collection was initiated at
2000 hour on Day 1 for urinary free cortisol and continued until
2000 hour on Day 2. An intravenous catheter was inserted in
each arm at 1900 hour on Day 2. Blood sampling (2cc ⁄ sample) at
10-minute intervals was initiated at 2000 hour continued through
0800 hour on Day 3. Sampling was obtained manually by nursing
staff. Significant efforts were made to avoid waking subjects while
asleep; the intravenous port was 6 inches from the subject, allowing
blood drawer without subject contact, and a focused light was used
to avoid unnecessary illumination. Following the 0800 hour blood
draw on Day 3, cosyntropin 0.01 lg ⁄kg was administered intrave-
nously over one minute. Blood sampling frequency was increased
immediately following cosyntropin administration every five minutes
through 0900, and then decreased every 10 minutes through
Table 1. Demographic and Clinical Characteristics of Alcohol-Dependent Subjects and Healthy Controls (mean ± SD)
Alcohol-dependent (n = 7) Controls (n = 11) t or X2 DF p Value
Age 36.2 ± 5.5 37.0 ± 4.9 0.285 16 0.779
Race









Employed 5 11 3.536 1 0.060
Education (yrs) 12.3 ± 2,0 14.7 ± 2.2 2.47 14 0.027
Nicotine dependent (smokers) 5 1 7.481 1 0.006
Alanine aminotransferase (U ⁄ l) 30.5 ± 13.3 15.7 ± 6.2 )3.10 15 0.007
Aspartate aminotransferase (U ⁄ l) 26.5 ± 10.2 18.2 ± 4.1 )2.34 15 0.033
GGTP 130.5 ± 118.6 9.5 ± 7.8 )3.23 15 0.006
Comparisons between groups were by t-test or chi-squared.
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1000 hour. Intravenous lines were removed following the final
1000 hour blood draw.
Session B. This study included the pituitary and adrenocortical
response to dexamethasone and the cosyntropin stimulation test
following dexamethasone. Subjects arrived at the GCRC
at 2000 hour, and intravenous lines were placed into both arms
at 2100 hour. Blood samples for the measurement of ACTH and cor-
tisol were obtained every 10 minutes from 2200 through 2300 hour.
Dexamethasone 8 mg in 50 ml of D5W was administered intrave-
nously from 2300 to 2330 hour. Blood sampling was continued from
2300 to 0500 hour, and then restarted at 0700 to 0800 hour every
10 minutes. (Blood sampling was not obtained from 0500 to
0700 hour because of limitations on blood volume.) The cosyntropin
test was performed as described in Session A. Cosyntropin was
administered at 0800 hour to assure that dexamethasone (adminis-
tered 9 hours previously) would continue to maximally suppress
endogenous ACTH release throughout the cosyntropin paradigm.
Assays
Plasma concentration of ACTH was measured by immunoradio-
metric assay (IRMA), using reagents from DiaSorin (Stillwater,
Minnesota). This assay has a low-end sensitivity of 1.5 pg ⁄ml, with
intra-assay coefficient of variation of 2.5 to 5.4% in the concentration
range of 33 to 773 pg ⁄ml. Inter-assay coefficient of variation is 3.2 to
5.7% in the concentration range of 8.7 to 257 pg ⁄ml. Serum concen-
tration of cortisol was measured by radioimmunoassay (RIA) using
reagents from DiaSorin. This assay has a low-end sensitivity of
0.21 lg ⁄dl, with intra-assay coefficient of variation of 6.6 to 7.7% in
the concentration range of 2.9 to 47.1 lg ⁄dl. Inter-assay coefficient
of variation is 8.8 to 9.8% in the concentration range of 3.7 to
36.9 lg ⁄dl. RIA kits from DiaSorin were used for the measurement
of urinary free cortisol.
Statistics
Demographics. Students t-test (interval data) and chi square
contingency table analyses (nominal data) were used to compare
demographic characteristics of the 2 groups. Items of interest
included age, education, employment status, marital status, liver
function, and smoking status. Descriptive statistics were used to
quantify drinking characteristics of the alcohol-dependent group
including years of problem drinking, drinking days (90 days prior
to drinking cessation and lifetime), and days abstinent at the time
of testing. Students t-test was used to compare mean scores on the
BDI and the DrInC-2L.
Basal ACTH and Cortisol Pulsatile Characteristics. Because
there is a circadian rhythm for the 2 hormones of interest, the
assumption that all secretion was pulsatile leads to unreasonably long
half-lives for ACTH and cortisol, resulting in a poor fit of the calcu-
lated pulses to the actual data. Therefore, pulsatile characteristics
were assessed by the Smoothing Baseline Pulse Pulses (SBPP) algo-
rithm (Guo et al., 1999), which allows for a changing baseline. In
general, missing values were not an issue in these data, but equally
spaced observations are required for analysis in pulse detection algo-
rithms. Missing values were handled in the following way: if the con-
centration at the time point preceding the missing time point was
lower than at the point after the missing time point, the missing con-
centration was replaced with the concentration value of the point pre-
ceding the missing time. This was carried out in order to avoid
creating the possibility of a pseudo-pulse. Missing values that were
part of a decreasing trend were linearly interpolated. For various rea-
sons, some series had to be excluded from the secondary analysis,
mainly because they did not show pulsatility. Pulsatile analysis was
completed on seven alcohol-dependent and nine control subjects for
ACTH and cortisol analyses. A Student t-test was used to compare
group means. A brief description of some of summary measures from
SBPP is given in the following paragraph:
Total Probability
The sum of the probabilities of being a pulse at each point.
Adjusted Input
The sum of input at each time point times the probability of input
at each point. It is a weighted total input.
Number of Inputs
The number of input locations with a probability > 0.5. SBPP
models the probability of input at each time point and we are using
the 0.5 cut off to distinguish large input (where input is most likely
occurring) from small (unlikely) input locations. This measure allows
the comparison of input frequencies between the 2 groups, but is not
a measure of pulse number.
Average Baseline
The mean of the baseline values estimated at each point.
SBPP allows for a changing baseline so baseline itself is no longer a
parameter.
Mean Amplitude
The net mean height of pulses after subtracting the changing
baseline.
Time · Group Analysis. A repeated measure analysis of variance
(ANOVA) on the mean hormone level over 4 3-hour blocks (i.e.,
2000–2250, 2300–0150, 0200–0450, and 0500–0800 hour) was
performed in order to incorporate all subjects into the circadian
analysis.
Pharmacologic Challenge Studies. Cortisol secretion following
cosyntropin was compared between the hours of 0800 and 1000 hour
by the area under the curve method (AUC), or net integrated
response, and by net peak cortisol for both Studies A and B. The net
integrated response was calculated by taking the average hormone
concentration between consecutive measurement points, multiplying
by the time interval between the points, summing across time, and
netting out basal hormone levels multiplied by the total time interval
over which measurement occurred (i.e., 120 minutes). Four subjects
revealed a negative integrated cortisol response following cosyntropin
(without dexamethasone pretreatment) as their final cortisol concen-
trations decreased below their basal measures. Thus, the integrated
cortisol response was also determined over 60 minutes for this study.
Basal hormone values were based on mean levels between the hours
of 0730 and 0800. The response to dexamethasone was determined
using mean ACTH or cortisol response from 2330 to 0500 hour. For
each analysis, Students t-test was used to compare group means.
Missing values were estimated based on the mean of hormone mea-
sures taken directly before and after the missing values. Two subjects
(one patient, one control) had several continuous data points missing
following dexamethasone (after 0030 hour). Because of the stability
of these measures, missing values were estimated as for the single
missing measures just described. Because of technical problems, data
from one control was included only for Study A and another control
was included only for Study B.
Effect Sizes. Effect sizes (assuming an a = 0.05 and b = 0.80)
were determined using DSTPLAN software.
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Correlation Analysis. The relationship between drinking his-
tory (i.e., drinks in previous 30 days, lifetime drinks, days abstinent)
and smoking history (nicotine pack years) and various neuro-
endocrine measures [basal cortisol concentration prior to
cosyntropin administration (without dexamethasone), integrated
cortisol response following cosyntropin, mean ACTH response to
dexamethasone, and integrated cortisol response following cosyntro-
pin with dexamethasone pretreatment] was assessed by (Pearson)
correlation.
RESULTS
Subject Characteristics (see Table 1)
The 7 alcohol-dependent women were similar in race
(p < 0.19) but more likely to be unemployed (p < 0.06) and
smokers (p < 0.008) relative to the healthy controls.
Alcohol-dependent subjects scored 35.8 ± 4.7 on the DrInC
and reported 18.1 ± 17.2 years drinking. TLFB revealed
49,311.6 ± 36,246.4 lifetime standard drinks and heavy
drinking over the 90 days prior to admission (1253.1 ± 477.0
drinks in the previous 90 days or 13.9 ± 5.3 drinks ⁄day).
Alcohol-dependent subjects were abstinent 41.1 ± 16.4 days
(19 to 68 days) at the time of their first study session.
Urinary Free Cortisol (see Table 3)
There was not a significant difference in urinary free corti-
sol between the alcohol-dependent and control groups.
Secretory Characteristics and Mean Basal Concentrations
of ACTH and Cortisol (see Table 2 and Figs. 1 and 2)
Secretory characteristics were determined by SBPP, an
algorithm to assess pulsatility that allows for a changing base-
line. One healthy control was excluded from the SBPP analy-
sis because of several missing measurements. As a reasonable
fit was not detected for ACTH profile of 2 patients, these
subjects were also excluded from the SBPP analysis on
ACTH. Neither ACTH nor cortisol pulsatile characteristics
significantly differed between the 2 groups. As expected,
the Time · Group ANOVA analyses showed a significant
within group Time effect [F(3,45) = 72.1, p < 0.0001]
for ACTH 3-hour blocks. However, there was no Group
[F(1, 14) = 0.33, p = 0.58] or Group · Time [F(3, 42) = 0.15,
p = 0.93] effect. Similarly, there was a significant Time effect
[F(3, 42) = 98.9, p < 0.0001] but not a Group [F(1, 14) = 1.97,
p = 0.18] or Group · Time [F(3, 42) = 0.60, p = 0.62]
effect for the cortisol 3-hour blocks. Exploratory post hoc
assessment (Table 2) of each 3-hour block period revealed
a nonsignificant decrease (p < 0.07) in cortisol during the
0200–0500 hour block in alcohol-dependent subjects com-
pared to the controls but no other significant group
differences for either hormone (see Fig. 2).
Cosyntropin Stimulation Test (see Table 3 and Fig. 3)
The net peak cortisol response in the control female group
was similar to that previously observed in male controls
(Adinoff et al., 2005a) (men: 8.7 ± 3.5, women: 7.8 ± 1.7;
t = 0.73, df = 18, p = 0.47). The cortisol response to low-
dose cosyntropin, as described by net integrated response
(integrated response from 0800 to 1000 hour minus the mean
basal concentration from 0730 to 0800), was not significantly
different between the 2 groups. As the net integrated response
in 4 subjects (3 controls, 1 patient) was negative as a result of
their final cortisol concentrations decreasing to less than
basal measures, the integrated net response from 0800 to
0900 hour (during which cortisol levels remained above basal
Table 2. ACTH and Cortisol (mean ± SD) Pulsatile Characteristics as Determined by Smoothing Baseline Pulse Pulses (SBPP) Analysis and Mean ACTH
and Cortisol Concentrations Over 12 Hours (2000 to 0800 Hour) and in 3-Hour Blocks. See Text for Description of SBPP Measures.
Healthy controls Alcohol-dependent T-stat df p Value Effect size
ACTH pulsatile characteristics
Total probability 20.3 ± 12.5 13.0 ± 12.4 1.05 12 0.32 0.6
Adjusted input 138.7 ± 81.8 100.2 ± 96.1 0.76 12 0.47 0.4
Number of inputs 17.5 ± 13.7 12.4 ± 11.6 0.74 12 0.47 0.4
Average baseline 14.6 ± 4.2 20.5 ± 9.3 )1.34 12 0.24 0.9
Mean amplitude 7.0 ± 3.6 9.3 ± 3.5 )1.15 12 0.28 0.7
Mean ACTH concentrations (pg ⁄ ml)
2000–2300 hour 14.0 ± 4.8 15.8 ± 5.7 )0.75 14 0.46
2300–0200 hour 17.6 ± 5.4 19.4 ± 8.7 )0.50 14 0.63
0200–0500 hour 24.5 ± 3.2 27.0 ± 9.3 )0.68 14 0.52
0500–0800 hour 29.9 ± 5.8 32.8 ± 9.2 )0.77 14 0.46
Cortisol pulsatile characteristics
Total probability 14.1 ± 6.7 16.3 ± 8.0 )0.58 14 0.57 0.3
Adjusted input 36.7 ± 14.3 33.3 ± 11.4 0.74 14 0.61 0.3
Number of inputs 12.7 ± 5.7 14.1 ± 6.5 )0.44 14 0.67 0.2
Average baseline 2.3 ± 1.8 2.0 ± 1.3 0.38 14 0.71 0.2
Mean amplitude 3.0 ± 1.2 2.3 ± 1.0 1.35 14 0.20 0.6
Mean cortisol concentrations (lg ⁄ dl)
2000–2300 hour 2.6 ± 1.1 2.5 ± 1.1 0.31 14 0.76
2300–0200 hour 3.5 ± 2.3 2.3 ± 0.9 1.40 14 0.19
0200–0500 hour 7.7 ± 1.7 5.9 ± 2.1 1.93 14 0.07
0500–0800 hour 11.4 ± 1.4 10.1 ± 2.7 1.33 14 0.21
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concentrations) was also determined. There was not a
between-group difference between net integrated response
during this 1-hour period (control subjects = 3099.0 ±
618.3 lg ⁄dl ⁄1 hour; patients: 4111.78 ± 581.3 lg ⁄dl ⁄1 h;
t = 0.93, df = 15, p = 0.36). The net cortisol peak response
to cosyntropin was somewhat higher in the control group
relative to the patients, although this difference did not reach
statistical significance (p < 0.08). As seen in Fig. 3, cortisol
concentrations were somewhat higher (from 15 to 25 minutes)
following cosyntropin administration in the control relative to
the patient group, although the early (5 to 10 minutes) and
later (30 to 120 minutes) time points were nearly identical
between groups.
Dexamethasone Suppression of ACTH and Cortisol
(Table 3 and Fig. 4)
Dexamethasone 8 mg was administered intravenously at
2300 hour, and the ACTH and cortisol response was assessed
from 2300 to 0500 hour. ACTH was somewhat lower in the
control group relative to the patients, although this difference
did not reach statistical significance. There were no between-
group differences in cortisol following dexamethasone. Both
groups suppressed ACTH concentrations to levels approxi-
mately 50% of those observed during peak hours and
mean cortisol concentrations were below 3.2 lg ⁄dl (mean)
from 0230 hour until the administration of cosyntropin at
0800 hour.
Dexamethasone + Cosyntropin Stimulation Test (see
Table 3 and Fig. 5)
Cosyntropin (0.01 lg ⁄kg) was administered following
dexamethasone suppression of endogenous ACTH. One
healthy control was excluded because of missing data. Just
prior to cosyntropin administration, ACTH and cortisol
mean concentrations (0730 to 0800 hour) were similar
between the groups. The net peak cortisol response in the con-
trol female group was nearly identical to that previously
observed in male controls (Adinoff et al., 2005a) (men:
15.8 ± 2,9, women: 16.1 ± 3.0; t = 0.20, df = 18, p =
0.84). The net integrated and net peak cortisol responses to
the cosyntropin challenge were nearly identical between the
alcohol-dependent and control women.
Correlations Between Neuroendocrine Measures and
Drinking and Smoking History
The relationship between drinking history (i.e., drinks in
previous ninety days, lifetime drinks, days abstinent) and
neuroendocrine measures that demonstrated a trend toward
statistical significance between groups (mean basal cortisol
0200–0500 hour, mean cortisol peak response following
cosyntropin) were considered. Correlations between neuro-
endocrine variables and pack years smoking were also
assessed. There were no significant correlations observed.
Fig. 1. Study design of pulsatility and cosyntropin ⁄ dexamethasone chal-
lenges. Session A: 24-hour urinary free cortisol (not shown) was obtained
from 2000 to 2000 hour prior to the pulsatility measures. ACTH and cortisol
concentrations were obtained from 2000 to 0800 to determine baseline pul-
satile characteristics. Cosyntropin (0.03 lg ⁄ kg) was administered at 0800 to
assess adrenocortical sensitivity. Session B: Dexamethasone (8 mg IV)
was administered at 2300 to suppress endogenous ACTH secretion and to
assess pituitary corticotroph sensitivity. Cosyntropin was administered at
0800 to assess adrenocortical sensitivity in the relative absence of endoge-
nous ACTH. Sessions were counter-balanced. Blood draws for ACTH and
cortisol concentrations were obtained every 10 minutes during all the inter-
vals noted, except blood draws were increased to every 5 minutes for 1 hour
after cosyntropin infusions.
Fig. 2. This figure illustrates the Smoothing Baseline Pulse Pulses
(SBPP) of 12 hours (2000 to 0800 hour) of ACTH and cortisol data from
a single subject. SBPP decomposes the hormone profile (solid line in
top panel) into a slowly changing baseline (dotted line in top panel) and
fast changing pulses (bottom two panels). (A) The original data (solid
line), its fitted values (dashed line) and the estimated baseline (dotted
line). ACTH measures are on top and cortisol measures on the bottom.
(B) The estimated pulse inputs of ACTH. (C) The estimated pulse inputs
of cortisol.
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DISCUSSION
These findings suggest that adrenocortical reactivity, pitu-
itary corticotroph sensitivity, and ACTH and glucocorticoid
circadian rhythmicity does not significantly differ between
abstinent alcohol-dependent women and healthy control
women. Although there was a suggestion of a blunted
cortisol peak response in the alcohol-dependent group fol-
lowing cosyntropin, neither the net integrated response to
cosyntropin nor the peak or integrated cortisol response
to cosyntropin following dexamethasone, more rigorous
assessments of adrenocortical reactivity, significantly differed
between groups. These findings are notably different from
those previously reported in male alcohol-dependent sub-
jects using a nearly identical paradigm (Adinoff et al.,
Table 3. Urinary Free Cortisol and Basal and Stimulated ACTH and Cortisol Response to Cosyntropin (0.01 lg ⁄ kg intravenously), Pituitary–Adrenal
Response to Intravenously Dexamethasone (8 mg intravenously), and Cosyntropin Following Dexamethasone Pretreatment (mean ± SD)
Healthy
controls Alcohol-dependent t stat df p Value
Effect
size
24-hour urinary free cortisol (g ⁄ 24 hour) 69.0 ± 38.7 63.9 ± 29.8 0.27 13 0.79
Cosyntropin stimulation test without dexamethasone
Mean basal ACTH (pg ⁄ ml) (0730–0800 hour) 26.7 ± 7.9 33.3 ± 7.2 1.762 15 0.09 0.9
Mean basal cortisol (lg ⁄ dl) (0730–0800 hour) 10.4 ± 2.9 10.9 ± 2.4 0.367 15 0.72 0.2
Net AUC of cortisol following cosyntropin (lg ⁄ dl.2 hour) 249.5 ± 265.0 199.8 ± 239.7 0.396 15 0.69 0.2
Net peak cortisol response following cosyntropin (lg ⁄ dl) 7.8 ± 1.7 6.3 ± 1.7 1.846 15 0.08 0.4
Dexamethasone followed by cosyntropin
Mean ACTH response following DEX (2330–0500 hour)
(pg ⁄ ml)
9.7 ± 3.2 12.7 ± 5.5 1.331 14 0.20 0.7
Mean cortisol response following DEX (lg ⁄ dl)
(2330–0500 hour)
2.1 ± 1.7 1.4 ± 0.2 1.114 15 0.28 0.6
Mean basal ACTH (pg ⁄ ml) (0730–0800 hour) 8.3 ± 3.9 11.1 ± 4.8 1.267 14 0.22 0.7
Mean basal cortisol (lg ⁄ dl) (0730–0800 hour) 1.1 ± 0.3 1.3 ± 0.7 0.738 14 0.47 0.4
Net AUC of cortisol response following cosyntropin
(lg ⁄ dl.2 hour)
957.4 ± 258.7 994.4 ± 131.7 0.316 14 0.75 0.2
Net peak cortisol response following cosyntropin (lg ⁄ dl) 13.9 ± 3.3 13.5 ± 1.5 0.300 14 0.76 0.2
AUC, area under the curve method.
Fig. 4. Mean ± SEM of cortisol concentrations. Cosyntropin (0.01 lg ⁄ kg
intravenously) was administered at 0800 hour. Healthy control subjects are
closed circles; alcohol-dependent subjects are open circles.
Fig. 5. Mean ± SEM of ACTH (upper panel) and cortisol (lower panel)
concentrations. Dexamethasone (8 mg intravenously) was administered
at 2300 hour. Cosyntropin (0.01 lg ⁄ kg intravenously) was administered at
0800 hour. Healthy control subjects are closed circles; alcohol-dependent
subjects are open circles.
Fig. 3. Mean ± SEM of ACTH (upper) and cortisol (lower) basal concen-
trations. Measures between 2000 and 0800 hours reflect basal concentra-
tions. Healthy control subjects are closed circles; alcohol-dependent
subjects are open circles.
ADRENOCORTICAL RESPONSIVENESS IN ALCOHOL-DEPENDENT WOMEN 921
2005a). The primary shared finding in both male (Adinoff
et al., 2005a) and female alcohol-dependent subjects were
somewhat lower basal cortisol concentrations in the early
morning (0200 to 0500 hour). Even though statistically mar-
ginal, however, relatively higher basal ACTH concentra-
tions and lower cortisol concentrations in the early morning
hours and somewhat higher post-dexamethasone ACTH
concentrations in alcohol-dependent women, relative to
controls, could suggest a disruption in feed forward and
feedback mechanisms.
The small n of our sample was a major limiting factor.
This limitation was mitigated, at least in part, by the care-
fully selected subject sample (no lifetime history of Axis I dis-
orders occurring in the absence of recent or ongoing alcohol
use, no recent use of psychotropics, a confined period of
abstinence, no ongoing use of oral contraceptives, premeno-
pausal women studied during the early follicular phase of
their menstrual cycle), the heavy drinking in all patients (at
least 450 drinks in the 90 days prior to admission), frequent
plasma sampling, and the use of multiple endocrine mea-
sures. The 2 groups were also age-matched, although they
differed in education levels and family history of other
psychiatric disorders (the latter was cause for exclusion only
in the controls).
Further limitations included: (i) diurnal measures using
only 12 hours of sampling. This time course, however,
includes the period most likely to demonstrate pathological
alterations (during peak activity). (ii) The use of manual
blood withdrawal techniques may have disrupted sleep pat-
terns, effecting ACTH and cortisol pulsatility. Although
efforts were taken to avoid awakening subjects, we did not
obtain objective measures of sleep disruption or potential
mood disturbances that could have resulted. (iii) The adminis-
tration of pituitary–adrenal challenges are typically performed
in the late afternoon or early evening, although Dickstein and
colleagues (1997) has reported that the cortisol response to a
submaximal dose of cosyntropin is similar at 0800 and
1600 hour. (iv) In order to study all women during the same
time of their menstrual phase, the alcohol-dependent women
were studied following a somewhat longer period of absti-
nence (41.4 ± 16.4 days) than the previously reported male
subjects (31.0 ± 4.0 days). (v) Alcohol-dependent women
smoked significantly more than their control counterparts.
This confound generally plagues most clinical laboratory
research of substance abusers, as most substance-dependent
patients smoke and most healthy volunteers without medical
or psychiatric morbidity, particularly in the age range of our
patient population, do not. Anthenelli and colleagues (2001)
has reported that nicotine dependence does not account for
the HPA axis alterations observed in alcohol-dependent men.
Although the acute nicotine use stimulates the HPA axis
(Mendelson et al., 2008), our nicotine-dependent subjects had
not smoked for several hours prior to study initiation and
nicotine patches were placed well before study onset.
Although subjects were not assessed for nicotine withdrawal
symptoms, recently abstinent smokers show stable cortisol
circadian concentrations when placed on a nicotine patch
(Teneggi et al., 2002).
Despite the potential confounds, many of the findings were
unequivocally negative. For instance, the glucocorticoid
response to cosyntropin following dexamethasone was nearly
identical in both groups, and effect sizes for our primary mea-
sures (net AUC cortisol response) were small. Approximately
400 subjects per group would have been required to detect sig-
nificant group differences in the net AUC cortisol following
either cosyntropin or cosyntropin following dexamethasone.
In contrast, this paradigm revealed one of the strongest group
differences in the male populations (Adinoff et al., 2005a). In
addition, the numerical elevation in ACTH response to dexa-
methasone in the alcohol-dependent women (suggesting a
muted pituitary corticotroph sensitivity to glucocorticoid
feedback) was also in the opposite direction to the increased
pituitary corticotroph sensitivity (i.e., decreased ACTH
response) observed in the male patient population.
The absence of glucocorticoid hyporeactivity in the
alcohol-dependent women was unexpected. As noted, adreno-
cortical hyporeactivity has been previously reported in male
alcohol-dependent subjects. In addition, Heim and colleagues
(2001) has observed that nondepressed women with child-
hood abuse show a blunted glucocorticoid response to cosyn-
tropin compared to nonabused control group. Although we
did not assess abuse in our study population, previous work
in this area would suggest that the alcohol-dependent women
had experienced significantly more childhood abuse than our
healthy control group (Felitti et al., 1998; Kendler et al.,
2000; Sher et al., 1997). Nevertheless, neither the chronic use
of alcohol nor presumed trauma history appeared to result in
altered adrenocortical reactivity.
Most studies demonstrating a blunted cortisol response in
alcohol-dependent men have used stimuli that induce gluco-
corticoid release indirectly through pituitary ACTH (Adinoff
et al., 2005b; Bailly et al., 1989; Chalmers et al., 1978; Coiro
et al., 2007; Coiro and Vescovi, 1999; Costa et al., 1996;
Errico et al., 1993; Lovallo et al., 2000; Margraf et al., 1967;
Merry and Marks, 1972; Vescovi et al., 1997). As some
(Coiro et al., 2007; Coiro and Vescovi, 1999; Vescovi et al.,
1997), but not all (Adinoff et al., 2005b; Bailly et al., 1989), of
these paradigms also report a concurrent blunting of ACTH
stimulation, the apparent adrenocortical hyporesponsivity
may be a consequence of an attenuated upper-level stimulus.
Other studies do not report differences in glucocorticoid
responsiveness in alcohol-dependent subjects even in the pres-
ence of a muted ACTH response (Adinoff et al., 1990; Inder
et al., 1995) or an exaggerated, not subdued, glucocorticoid
response is observed (Anthenelli et al., 2001; George et al.,
1994). In fact, Brady and colleagues (2006) reported a blunted
ACTH response in alcohol-dependent men and women fol-
lowing a cold pressor task that was more marked (albeit non-
significantly) in women than men. Cortisol concentrations,
however, showed no between-group (alcohol-dependent vs.
controls) or gender (men vs. women) differences (Brady et al.,
2006). Using only single basal measures during abstinence,
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Gianoulakis et al. (2003) reported that plasma cortisol was
higher in 30 to 60 y ⁄o alcohol-dependent men in treatment
relative to sex-matched nondrinkers, whereas female alcohol-
dependent women did not significantly differ from their non-
drinking comparison group.
Alcohol-dependent men and women differ in their genetic,
social and personality vulnerabilities to alcohol dependence,
their initial onset of disease progression, and the long-term
consequences of heavy alcohol use (Nolen-Hoeksema and
Hilt, 2006; Walitzer and Dearing, 2006). The unanticipated
findings in the present study emphasize the importance in
assessing the neurobiological disruptions in both male and
female alcohol-dependent subjects that may underlie these
clinical differences. Of potential relevance is evidence suggest-
ing that long-acting naltrexone is effective in preventing alco-
hol relapse in men and not women (Garbutt et al., 2005). A
possible mechanism of naltrexone is its disinhibiting effects
upon the HPA axis, thus mitigating the pituitary–adrenal sup-
pression that accompanies chronic alcohol dependence in
men (Adinoff et al., 1998). If alcohol-dependent women do
not suffer from a similar deficit in the HPA axis, then naltrex-
one may, at least in part, lose some of its effectiveness. Future
studies should continue to explore HPA deficits in female
alcohol-dependent women, including higher level (i.e., pre-
frontal cortex, limbic system, hypothalamus, pituitary) dis-
ruptions, the relationship of HPA alterations to prior trauma
and adverse life events, the predictive effects of HPA axis
alterations and relapse, and the effects of pharmacological
interventions upon the HPA axis.
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